MyEClinic
MyEClinic
Health Dictionary Find a Doctor

DCEP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Overview

DCEP regimen refers to a regimen consisting of Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients.[1]

Regimen

Regimen

DDexamethasone

CCyclophosphamide

EEtoposide

PCisplatin

Indications

Indications

References

References

  1. ↑ 1.0 1.1 Dadacaridou M, Papanicolaou X, Maltesas D, Megalakaki C, Patos P, Panteli K; et al. (2007). “Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients”. J BUON. 12 (1): 41–4. PMID 17436400.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH